Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells

Chemico-Biological Interactions

Volumn 177, Issue 1, 2009, Pages 7-11

  Choi, Eun Jeong ^a,b   Ahn, Woong Shick ^a   Bae, Su Mi ^a  

^a The Catholic University of Korea   (South Korea)

^b Duksung Women's University   (South Korea)

Author keywords

Apoptosis; Caspase cascade; Cell proliferation; Equol; Human breast caner cells

Indexed keywords

CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; EQUOL; LAMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL;

APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; ENZYME ACTIVATION; HUMANS; ISOFLAVONES;

EID: 57349119001     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.031     Document Type: Article

References (28)

1. Ren W., Qiao Z., Wang H., Zhu L., and Zhang L. Flavonoids: promising anticancer agents. Med. Res. Rev. 23 (2003) 519-534
2. Weber G. Down-regulation of increased signal transduction capacity in human cancer cells. Adv. Enzyme Regul. 45 (2005) 37-51
3. Fulda S., and Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (2006) 4798-4811
4. Prados J., Melguizo C., Boulaiz H., Marchal J.A., and Aranega A. Cancer gene therapy: strategies and clinical trials. Cell Mol. Biol. 51 (2005) 23-36
5. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103 (2005) 1551-1560
6. Philchenkov A., Zavelevich M., Kroczak T.J., and Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp. Oncol. 26 (2004) 82-97
7. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 18 (2007) 427-442
8. Gercel-Taylor C., Feitelson A.K., and Taylor D.D. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res. 24 (2004) 795-800
9. Hedlund T.E., van Bokhoven A., Johannes W.U., Nordeen S.K., and Ogden L.G. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Prostate 66 (2006) 557-566
10. Guo J.M., Xiao B.X., Liu D.H., Grant M., Zhang S., Lai Y.F., Guo Y.B., and Liu Q. Biphasic effect of daidzein on cell growth of human colon cancer cells. Food Chem. Toxicol. 42 (2004) 1641-1646
11. de Lemos M.L. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 35 (2001) 1118-1121
12. Rassi C.M., Lieberherr M., Chaumaz G., Pointillart A., and Cournot G. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J. Bone Miner. Res. 17 (2002) 630-638
13. Totta P., Acconcia F., Virgili F., Cassidy A., Weinberg P.D., Rimbach G., and Marino M. Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J. Nutr. 135 (2005) 2687-2693
14. Su S.J., Chow N.H., Kung M.L., Hung T.C., and Chang K.L. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr. Cancer 45 (2003) 113-123
15. Linford N.J., Yang Y., Cook D.G., and Dorsa D.M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 299 (2001) 67-75
16. Cooke G.M. A review of the animal models used to investigate the health benefits of soy isoflavones. J. AOAC Int. 89 (2006) 1215-1227
17. Messina M., Kucuk O., and Lampe J.W. An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J. AOAC Int. 89 (2006) 1121-1134
18. Sarkar F.H., and Li Y. Soy isoflavones and cancer prevention. Cancer Invest. 21 (2003) 744-757
19. Hwang J., Wang J., Morazzoni P., Hodis H.N., and Sevanian A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic. Biol. Med. 34 (2003) 1271-1282
20. Rufer C.E., and Kulling S.E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem. 54 (2006) 2926-2931
21. Magee P.J., Raschke M., Steiner C., Duffin J.G., Pool-Zobel B.L., Jokela T., Wahala K., and Rowland I.R. Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr. Cancer 54 (2006) 232-242
22. Sathyamoorthy N., and Wang T.T. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer 33 (1997) 2384-2389
23. Haghiac M., and Walle T. Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells. Nutr. Cancer 53 (2005) 220-231
24. Choi E.J., and Kim T. Equol induced the apoptosis via cell cycle arrest in MDA-MB-453 but not in MCF-7 cells. Mol. Med. Rep. 1 (2008) 239-244
25. Kumar S. Caspase function in programmed cell death. Cell Death Differ. 14 (2007) 32-43
26. Kojima K., Konopleva M., McQueen T., O'brien S., Plunkett W., and Andreeff M. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Blood 108 (2006) 993-1000
27. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 (1994) 346-347
28. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998) 491-501